Correlation Between Andes Technology and Medigen Biotechnology

Can any of the company-specific risk be diversified away by investing in both Andes Technology and Medigen Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Andes Technology and Medigen Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Andes Technology Corp and Medigen Biotechnology, you can compare the effects of market volatilities on Andes Technology and Medigen Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Andes Technology with a short position of Medigen Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Andes Technology and Medigen Biotechnology.

Diversification Opportunities for Andes Technology and Medigen Biotechnology

0.19

Correlation Coefficient

Andes Technology  Medigen Biotechnology

Average diversification

The 3 months correlation between Andes and Medigen is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Andes Technology Corp and Medigen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medigen Biotechnology and Andes Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Andes Technology Corp are associated (or correlated) with Medigen Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medigen Biotechnology has no effect on the direction of Andes Technology i.e., Andes Technology and Medigen Biotechnology go up and down completely randomly.

Pair Corralation between Andes Technology and Medigen Biotechnology

Assuming the 90 days trading horizon Andes Technology Corp is expected to under-perform the Medigen Biotechnology. In addition to that, Andes Technology is 1.35 times more volatile than Medigen Biotechnology. It trades about -0.02 of its total potential returns per unit of risk. Medigen Biotechnology is currently generating about 0.1 per unit of volatility. If you would invest  3,180  in Medigen Biotechnology on December 23, 2024 and sell it today you would earn a total of  370.00  from holding Medigen Biotechnology or generate 11.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Andes Technology Corp  vs.  Medigen Biotechnology

Andes Technology Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Andes Technology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Andes Technology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Medigen Biotechnology

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Medigen Biotechnology are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Medigen Biotechnology showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Andes Technology and Medigen Biotechnology

The main advantage of trading using opposite Andes Technology and Medigen Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Andes Technology position performs unexpectedly, Medigen Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Biotechnology will offset losses from the drop in Medigen Biotechnology's long position.

The idea behind Andes Technology Corp and Medigen Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.